secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXICURE, INC. (XCUR)
CIK:        0001698530
Form:       8-K
Filed at:   2025-03-18T23:59:59+00:00
Accession:  0001698530-25-000017
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Exicure reports FY2024 net loss of $9.7M, cash $12.5M, going concern warning
----------------------------------------------------------------------------

- Cash and cash equivalents $12.5M as of Dec 31, 2024, up from $0.8M year-end 2023; management warns liquidity may not last 12 months.
- Net loss of $9.7M for FY2024, compared to net loss of $16.9M in FY2023; decrease driven by lower G&A and asset sale income.
- R&D expenses $0 for FY2024 (from $1.4M) reflecting cessation of all R&D activities; G&A expenses $5.4M (from $11.7M).
- Company continues exploring strategic alternatives, including transactions with potential partners; substantial doubt about going concern.
- Sold clinical product samples and certain assets in 2024 to a private biopharma; no further operational details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1698530/000169853025000017/0001698530-25-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1698530/000169853025000017/xcur-20250318.htm
  HTML page:      https://secwatch.observer/filing/0001698530-25-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer